ABSTRACT (219 words) 26
INTRODUCTION 45
Measurement of brachial artery (BA) flow-mediated vasodilation (FMD) following ischemic cuff 46 occlusion, first described by Celermajer et al. (1) , has been widely utilized in recent years as a non-47 invasive means of evaluating endothelial function in a research setting (10, 15, 17, 20, 36) . The 48 assessment of endothelial function via FMD has been proposed to represent a functional bioassay for 49 endothelium-derived NO bioavailability in humans (7, 16), though there is new evidence challenging the 50 view that FMD is a reliable and selective index of endothelial NO function (23) . Earlier work 51 demonstrated a positive correlation between endothelium-dependent vasodilation of the brachial and 52 coronary arteries (32), a finding that has fueled the ongoing interest in non-invasive evaluation of NO 53 bioactivity in humans. 54
The uncertainty surrounding conventional FMD testing has raised the question of whether a more 55 robust and comprehensive experimental paradigm might be adopted for the non-invasive determination of 56 vascular health. On such approach is dynamic handgrip exercise, first described by Shoemaker et al. (29) , 57 which elevates shear stress through the BA and produces a subsequent vasodilation. We have recently 58 identified the intensity-dependent nature of this response (25) , and also demonstrated a decline in BA 59 vasodilation in response to handgrip exercise in the elderly (6), a group known to suffer from impaired 60 endothelial function (30). However, the fundamental question of whether BA vasodilation during 61 handgrip exercise is NO-mediated has not been addressed. 62
Therefore, in the present study we tested the hypotheses that; 1) the brachial artery would 63 vasodilate in an intensity-dependent manner during incremental handgrip exercise, effectively producing 64 a step-wise series of "FMD" values in response to sustained shear rate, and 2) that this brachial artery 65 vasodilation would be due, at least in part, to endothelial-derived NO release. To test these hypotheses, 66 dynamic handgrip exercise at six different intensities was performed in the absence and presence of high
RESULTS

148
Subject characteristics are presented in Table 1 . 149 150 L-NMMA dose-response. During the L-NMMA dose-response, brachial artery (BA) blood flow 151 decreased significantly at all doses, with a plateau in vasoconstriction at the highest dose (0.48 mg/dl) 152 (Figure 1 ). This dose of L-NMMA also reduced BA shear rate (86 ± 13 to 59 ± 8 s -1 ) and BA mean blood 153 velocity (9 ± 1 to 4 ± 1 cm/s), while BA diameter, heart rate (HR), stroke volume (SV), cardiac output 154 (CO), and mean arterial blood pressure (MAP) were unchanged. Additionally, in the contra-lateral arm, 155 there were no changes in BA diameter, mean blood velocity, or blood flow (Figure 1 ) during any dose of 156 L-NMMA, confirming that the drug remained localized to the vasculature of the infused arm. 157 158 L-NMMA at rest. At rest, L-NMMA reduced resting BA mean blood velocity, blood flow, shear rate, and 159 vascular conductance (VC) by approximately 40%, while BA diameter remained unchanged during the 160 drug infusion (Table 2 and Figure 2) . Similarly, HR, SV, CO, and MAP were not affected by L-NMMA 161 (Table 2) , supporting the regional effect of the drug without measureable systemic effects. 162 163 L-NMMA during exercise. Prior to L-NMMA infusion, handgrip exercise resulted in an immediate and 164 intensity-dependent increase in BA mean blood velocity (Table 2) , vascular conductance (Table 2) , shear 165 rate (Figure 2A) , and blood flow ( Figure 3A) . No measureable increase in BA diameter was evident at 166 the lower (4-8-12 kg) exercise intensities, but significant BA vasodilation was present at 16-20-24 kg 167 (Table 2 and Figure 2B) . Likewise, at the higher exercise intensities, significant exercise-dependent 168 increases in HR, CO, MAP, VC were also observed ( Table 2) . After L-NMMA, blood flow was reduced 169 by 15-25% for any given exercise intensity, and the slope of BA blood flow across all exercise levels was 170 significantly reduced (slope = 84 ± 14 to 66 ± 13, control vs. L-NMMA, P = 0.036). (Figure 3A) . When 171 expressed as a change from baseline, blood flow was significantly reduced at the highest two exerciseNMMA (Figure 2A) , exercise-induced BA vasodilation was significantly blunted at the higher exercise 174 intensities in the presence of L-NMMA; at the highest (24 kg) work rate, L-NMMA administration 175 reduced exercised-induced BA vasodilation by ~70% ( Figure 2B) . As during the control exercise trial, 176 significant exercise-dependent increases in HR, CO, MAP, VC were observed during L-NMMA infusion, 177 but these responses were not different from the control trial (Table 2) . When BA diameter is viewed in 178 relation to shear rate during the exercise intensities where vasodilation was observed (16-20-24 Figure 3A ) and associated shear rate (Figure 2A) , exposing 210 the BA to a wide range of sustained shear force that resulted in a significant (~10%) vasodilation at the 211 higher exercise intensities ( Figure 2B ). These data extend recent work from our group utilizing a similar 212 handgrip exercise paradigm but with considerably lower work rates (3-6-9 kg) and cadence (0.5Hz) (6, 213 25), offering additional support for the use of this exercise modality in providing a wide-ranging shear 214 stimulus for comprehensive, non-invasive assessment of BA vasodilatory capacity. 215 216 Impact of eNOS blockade on BA vasodilation. Of equal importance to evaluation of the stimulus-217 response relationship described above is identifying what portion of the shear-induced BA vasodilation is 218 attributable to NO. To address this, we first determined the dose-response relationship for L-NMMA to 219 evaluate efficacy of the regional eNOS blockade. As can be seen in Figure 1 , a clear plateau was reached 220
in BA blood flow in the infused arm, such that a doubling dose of the drug did not elicit further 221 vasoconstriction. Importantly, the performance of this L-NMMA dose response did not produce a change 222 in BA blood flow in the contra-lateral (non-infused) arm or alter arterial blood pressure, supporting an 223 absence of measurable systemic effects during the local drug infusion. The highest dose of L-NMMA was 224 then administered during handgrip exercise to provide regional eNOS blockade. This intra-arterial doses 225 of L-NMMA (8.6 ± 0.9 mg/min) exceeds dosing reported elsewhere 226
(1-5 mg/min) as efficacious in achieving eNOS blockade during handgrip exercise (5, 8, 26) . 227
By design, L-NMMA was infused into the BA proximal to the portion of the vessel which was 228 imaged, producing eNOS blockade in all downstream vascular beds of the arm. The site of drug 229 administration was an important experimental consideration, ensuring that ultrasound measurements of 230 BA diameter were taken from a region fully exposed to the drug. Indeed, several previous studies have 231 infused NOS-blocking drugs in the arm distal to the site where blood velocity and diameter are measured, 232
and while these studies have been quite informative regarding the degree to which NO regulates exercise-233 induced hyperemia in the forearm (5, 9, 12, 14, 27, 28), they could not provide insight into exercise-234 induced BA vasodilation or the effect of NOS inhibition on this vasodilation. 235
With this approach, to our knowledge this is the first study to directly determine the contribution 236 of NO to exercise-induced vasodilation of the BA in humans. The BA vasodilation present in the control 237 trial (~10%) was greatly reduced (~3%) following L-NMMA, with only a minimal increase in BA 238 diameter at the highest exercise intensity (Figure 2B) , thus providing evidence that NO is a major 239 contributor (~70%) to BA vasodilation in this exercise paradigm. 240
241
The role of NO in exercise hyperemia. In addition to assessing the role of NO in conduit artery 242 vasodilation during exercise, the present study also afforded the opportunity to examine the contribution 243 of NO to overall exercise hyperemia. Previous studies using NOS inhibition during handgrip (9, (12) (13) (14) 244 27, 28) and knee-extensor (11, 24) exercise have collectively demonstrated a 10-20% reduction in skeletal 245 muscle blood flow in the presence of NOS blockade. Findings from these studies have led to the 246 prevailing view that the reduced hyperemic response in the presence of NOS blockade represents a 247 "downward shift" with a similar overall change in blood flow from rest to maximal exercise, such that 248 NO-mediated vasodilation is of little functional consequence to the overall hyperemia in the exercising 249
limb (33). 250
The present data differ from these former studies, identifying a 20-25% reduction in BA blood 251 flow in the presence of L-NMMA, accompanied by a reduced slope for blood flow across exercise 252 intensities in the presence of L-NMMA ( Figure 3A) . We contend that these responses represent more 253 than simply a downward shift with similar magnitude of change in blood flow; indeed, when the 254 hyperemic response is viewed as changes in blood flow, which take into account baseline differences 255 between trials, a significant difference remains at the higher exercise intensities ( Figure 3B ). This 256 disparity between previous studies and the present data are likely attributable to differences in the range 257 of exercise intensities, and the method by which blood flow is determined. Indeed, the majority of former 258 studies examining eNOS blockade during handgrip exercise did not examine the intensity-dependentstudy, producing BA blood flows as high as 600 ml/min in some individuals at the highest exercise 262 intensity. Other previous studies have examined the effects of L-NMMA on exercise hyperemia using 263 strain gauge plethysmography (9, 12, 13), which requires cessation of exercise for determination of blood 264 flow. The present study thus builds upon these previous studies through continuous Ultrasound Doppler 265 measurements and inclusion of wide ranging exercise intensities to more fully characterize the role of NO 266 during exercise. 267
This pattern of reduced perfusion during L-NMMA infusion at any given absolute exercise 268 intensity ( Figure 3A and 3B) could be viewed as evidence for the importance of NO to the vasodilatory 269 response for a given metabolic demand. The physiologic consequence of reduced perfusion for a given 270 VO 2 during exercise may not be trivial; indeed, it may be likened to that seen in the elderly during 271 exercise, when a 20-30% reduction in exercising leg blood flow must be met with an increase in a-v O 2 272 difference across the exercising muscle to ensure adequate O 2 availability (18, 22) . In this light, NO may 273 indeed act as an important player in the cast of vasodilators that collectively ensure proper matching of 274 perfusion and metabolism during exercise. 275
276
Implications. Due to the potential prognostic and diagnostic value of in vivo determinations of 277 endothelial health in preventative cardiology (19), the overall goal of the present study was to examine 278 the potential of handgrip exercise for non-invasive assessment of NO-dependent vasodilation. The need 279 for complimentary approaches has become increasingly apparent as FMD testing has been refined over 280 the past ten years (2, 15), a process that has brought to the forefront several noteworthy confounding 281 influences, including variance in the hyperemic response, the singular nature of results from FMD testing, 282 and uncertainty regarding whether the test truly reflects NO bioavailability (23). The present study 283 addresses each of these concerns by provoking sustained, step-wise increases in shear stimulus to the BA 284 that results in vasodilation. 285
The linear relationship between these variables, and the degree to which NO contributes to this 286 relationship, is illustrated in Figure 4 . In the control condition, an excellent correlation between the shearstimulus and subsequent vasodilation is exhibited in all individuals, with r values ranging from 0.97 to 288 0.99. This relationship is significantly diminished after L-NMMA administration, and the slope of the 289 vasodilatory response is likewise reduced by approximately 2/3rds. In practical terms, the slope calculated 290 from this array of stimulus-response values produced during a short bout of handgrip exercise provides a 291 numeric index of NO-dependent vasodilation, such that a reduced slope may be associated with impaired 292 endothelial function. This index (slope value) may be viewed as similar to the "percent vasodilation" 293 value reported with conventional FMD testing, but with the added advantage of including several serial 294 measurements in the same vessel across wide-ranging shear rates. Accordingly, we propose that handgrip 295 exercise does indeed represent a valid approach to non-invasively probe endothelial health and NO 296 bioactivity in humans. Certainly, further studies are required to evaluate the predictive capacity of this 297 paradigm for cardiovascular disease and outcomes, as has been established for traditional FMD (37). 298
299
Experimental Considerations: Due to the lasting effects of L-NMMA, the protocol was ordered such that 300 the control trial was always performed first. However, our group (35) and others (3) have previously 301 reported high reproducibility in the overall hyperemic response when multiple exercise bouts are 302 performed sequentially during infusion-based studies. We also acknowledge that the efficacy of L-303 NMMA to inhibit eNOS was not evaluated in the present study. However, this concern is somewhat 304 mitigated by the observed plateau in vasoconstriction at the highest doses of L-NMMA (Figure 1) and 305 support from previous work (4) reporting successful blockade at doses well below those administered in 306 the present study. It is also possible that the level of eNOS blockade present at rest was altered as a 307 consequence of the high-flow conditions during handgrip exercise. To minimize this risk, L-NMMA was 308 maintained at the same high dose used for drug loading (0.48 mg/dl) throughout the exercise protocol, 309 rather than the more conventional 1/5 th dose for maintenance (5, 8). We cannot exclude the possibility that 310 radial artery) to examine the role of NO on FMD (7, 23). Inter-observer variability was not evaluated in 314 the present study, but we have previously reported a coefficient of variation approximately 20% when 315 measuring brachial artery vasodilation in the same subject on multiple visits to the laboratory (21). 316
Finally, we wish to acknowledge that we did not determine blood flow during the recovery period 317 following exercise, which has been reported to differ following L-NMMA administration (13). 318 319 Summary. We have further characterized the handgrip exercise model as capable of producing the 320 requisite incremental and sustained shear stress and associated vasodilation needed to validate this 321 exercise modality as appropriate for assessment of BA vascular function. Additionally, we have identified 322
NO as a significant mechanism by which exercise-induced BA vasodilation is achieved. As such, these 323 findings lend credence to the use of handgrip exercise for non-invasive determination of NO-dependent 324 vasodilatory capacity in humans. 
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